Flowonix Stock
Flowonix is a medical device company developing solutions for patients with chronic disorders.
Sign up today and learn more about Flowonix Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Flowonix Stock
Flowonix is a medical device company dedicated to helping those who suffer from chronic disorders. Their team has decades of experience developing unique and reliable medical devices to improve lifestyles. Using one of a kind technology, Flowonix has developed an implantable drug pump designed to deliver therapeutic drugs into the spine to relieve a variety of chronic disorders and help patients return to normal lives.
Funding History
| May 2012 | $25.0M |
|---|---|
| November 2014 | $20.0M |
| June 2016 | $5.0M |
| September 2018 | $2.0M |
Management
Chief Financial Officer
Wayne Coll
Board of Directors
Kurt Wheeler
Founder
David Jenkins
Chief Executive Officer
Steve Adler
Board of Directors
Jon Tremmel
Board of Directors
David Jenkins
Press
globenewswire - Mar, 3 2024
Intrathecal Pumps Market Anticipated to Touch USD 405.6 million, Projected a CAGR of 4.5% by 2031: Transparency ...menafn - Feb, 1 2024
Interventional Pain Management Market Size, Report 2024 ...finance - Feb, 1 2024
Drug Infusion Systems Global Market Report 2023: Market is ...massdevice - Feb, 1 2024
First patients treated in trial of Magnus neurostim for depressionbioworld - Jan, 5 2021
Flowonix and Swk Holdings craft $33M financing dealEquityZen Recognized As:
